Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sinergi Inti Plastindo Tbk. (ESIP) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Sinergi Inti Plastindo Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Sinergi Inti Plastindo Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Sinergi Inti Plastindo Tbk. trades at Rp122 (market cap 135.41B, 8.77M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp238 (market cap 164.65B, 50.3K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Sinergi Inti Plastindo Tbk. is more actively traded (8.77M versus 50.3K). Which is the better fit depends on your goals.

ESIPOBAT
Market Cap
135.41B164.65B
Volume
8.77M50.3K
Lot
87.69K503
Turnover
1.06B12.13M
Average Price
121.34241.18
Value
1.06B12.13M
Indicative Equilibrium Price
123238
Indicative Equilibrium Volume
1.43K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ESIP
View details
OBAT
View details

About Sinergi Inti Plastindo Tbk.

PT Sinergi Inti Plastindo Tbk (the”Company”) was established based on the notarial deed No.123 dated October 12, 2001 from Dr. Irawan Soerodjo, S.H., M.Si., Notary in Jakarta. PT Tanindo Omega Pasifik is a ultimate parent entity.

Read more on ESIP

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT